Launching a Pharma Brand During a Pandemic

If you registered for the live event at the time, then please use the same link and access code to rewatch a recording of the live event video stream!


Dec 15 2020


8:15 am - 9:15 am

Please join the OPMA on Tuesday, December 15th, for an opportunity to meet three marketers who successfully launched brands during the COVID-19 Pandemic. These seasoned marketers will discuss their launch challenges, quick wins, strategies and more as they share their launch experiences. The panel discussion will be moderated by Dave Bard.


  • Dave Bard
    Dave Bard
    President & Founder, EMREACH Inc.

    Dave Bard is an entrepreneur, business leader and a published author. He has over twenty years of leadership experience in pharmaceutical and medical device commercial roles with leading healthcare companies in North America. Dave founded EMREACH Inc. in 2010 with the goal of helping pharma navigate and capitalize on the emerging technology of Electronic Medical Records. EMREACH has helped countless pharmaceutical marketers and patient program leads improve patient access and care by leveraging the capabilities of EMRs.

  • Gayle Jaroslawski
    Gayle Jaroslawski
    Senior Portfolio Manager, Bausch Health Canada, Inc.

    Gayle Jaroslawski, marketing geek and Senior Portfolio Manager at Bausch Health, has more than 15 years of pharmaceutical marketing experience and 5 brand launches under her belt. She has worked in multiple therapeutic areas, such as diabetes, allergy, cardiovascular, and most recently, dermatology, and has managed products in every stage of the life cycle, from pre-launch to loss of exclusivity.

    Gayle is passionate about building brands that connect with the prescribers and their patients and is driven by curiosity, always looking for new perspectives and approaches.

    Gayle used to love travelling, but these days she is happy to be able to spend more time at home with her family and her dog, Archie.

  • Jackie Marrie
    Jackie Marrie
    Strategy Lead, Darolutamide, Bayer Canada

    Started my career with Berlex, prior to integration into Bayer Canada. I have had the pleasure to gain experience across general and specialty medicine, in sales, sales management, training, market access and marketing. Successfully launched Adempas in a rare disease space and currently launching a novel anti-androgen into the advanced prostate cancer landscape.

  • Orest Sklierenko
    Orest Sklierenko
    Brand Lead, Oncology, Sanofi-Genzyme Canada

    A successful and experienced leader who has worked at global firms in the pharmaceutical and biotechnology industry, Orest is well respected for his ability to lead and inspire teams, strategic planning expertise and passion for delivering results. Orest’s successes in industry include leading the launches of a novel, highly specialized therapy for an ultra-orphan blood disorder, and a blockbuster drug for advanced cancer patients. Orest co-founded and launched Men’s Health Solutions, a company focused on the optimization of patient outcomes in male-specific diseases, which evolved to become Canada’s largest network of male health clinics.

    Orest has also worked as a healthcare consultant, helping clients evaluate and re-focus their strategic plans and programs. His past clients include: multi-national pharmaceutical and biotechnology companies, professional associations, healthcare start-ups, specialty and community pharmacies. Orest has dedicated a significant amount of his time volunteering for humanitarian, education, arts & culture organizations, ranging in scope from grassroots community organizations to national and international foundations. His ability to align a diverse set of stakeholders around a common cause and come to a mutually agreeable solution have been evidenced in a wide range of settings over the past decade.

    Orest is currently a member of the Oncology team at Sanofi Genzyme Canada. He looks forward to helping the team pursue its ambition to contribute meaningful solutions for patients who are battling cancer through drug discovery and development that is rooted in strong science and innovative technologies.

Join our Mailing list!

Get all latest news about our programs, subscribe to our newsletter!